Travellers with pre-existing medical conditions

被引:23
作者
Ericsson, CD [1 ]
机构
[1] Univ Texas, Sch Med, Dept Med, Div Infect Dis, Houston, TX 77030 USA
关键词
travel; travellers; immune compromised host; HIV; transplantation; malignancy; IgA deficiency; asplenia; corticosteroids; diabetes mellitus; end stage renal disease myocardial infarction; chronic obstructive pulmonary disease; gastrointestinal disease : cirrhosis; drug/drug interaction; education;
D O I
10.1016/S0924-8579(02)00288-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Medical conditions that influence travel include those that compromise the immunity of the traveller and chronic underlying diseases or infirmities. The former includes HIV, transplantation, malignancy and its treatment, IgA deficiency, asplenia and use of immunocompromising drugs like corticosteroids. Chronic conditions include diabetes mellitus, end stage renal disease, diseases associated with compromised cardiac or pulmonary function and certain gastrointestinal diseases including cirrhosis. This review includes practical approaches to each of these conditions with attention to risk assessment and avoidance, vaccination when appropriate and not a risk to the compromised host, and arming the traveller with self-therapy and chemoprophylaxis. Since travellers with underlying conditions are often taking various medications the travel health practitioner must be alert for possible drug/drug interactions and must adjust dosages depending on the level of compromised renal or hepatic function. Finally, education of such travellers is paramount; they must understand that risk avoidance is critical and preventative modalities such as vaccination and chemoprophylaxis are never 100% efficacious. (C) 2002 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 16 条
[1]   The human immunodeficiency virus-infected traveler [J].
Castelli, F ;
Patroni, A .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1403-1408
[2]  
Cox GR, 1996, AVIAT SPACE ENVIR MD, V67, P976
[3]   Travel-related morbidity in travelers with insulin-dependent diabetes mellitus [J].
Driessen, SO ;
Cobelens, FGJ ;
Ligthelm, RJ .
JOURNAL OF TRAVEL MEDICINE, 1999, 6 (01) :12-15
[4]  
FISCHER P, 1995, AM J TROP MED HYG, V53, P171
[5]  
GILBERT DN, 2002, SANFORD GUIDE ANTIMI
[6]   INSULIN-TREATMENT, TIME-ZONES AND AIR-TRAVEL - A SURVEY OF CURRENT ADVICE FROM BRITISH DIABETIC CLINICS [J].
GILL, GV ;
REDMOND, S .
DIABETIC MEDICINE, 1993, 10 (08) :764-767
[7]  
Giordano B P, 1989, Diabetes Educ, V15, P444
[8]   RELATIONSHIP BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND SALMONELLOSIS IN 20-YEAR-OLD TO 59-YEAR-OLD RESIDENTS OF NEW-YORK-CITY [J].
GRUENEWALD, R ;
BLUM, S ;
CHAN, J .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) :358-363
[9]   Studies on schistosomiasis in western Kenya .1. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections [J].
Karanja, DMS ;
Colley, DG ;
Nahlen, BL ;
Ouma, JH ;
Secor, WE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (05) :515-521
[10]  
LEWIS KT, 1995, AM FAM PHYSICIAN, V52, P479